REPH Recro Pharma Inc

Recro Pharma Inc is a specialty pharmaceutical company. It develops non-opioid products for treatment of serious acute pain. The Company operates through two business divisions: Acute Care division and contract development and manufacturing division.

$2.14
As of 09/16/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  03/07/2014
Outstanding shares:  46,614,535
Average volume:  240,238
Market cap:   $99,755,105
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    75629F109
ISIN:        US75629F1093
Sedol:      BJ35BP6
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy